India Diagnostic Imaging Services Market Report 2022 to 2030

India Diagnostic Imaging Services Market

$ 3999

The India Diagnostic Imaging Services market size was valued at $9.54 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.9 % from 2022 to 2030 and will reach $17.54 Bn in 2030. The market is segmented by product, application, and end user. The India Diagnostic Imaging Services market will grow as the development of new 3D printing materials and techniques has led to the production of more complex and customizable medical devices. The key market players are Wipro GE Healthcare Pvt. Ltd. (Bangalore), Siemens Healthcare Private Limited (Gurgaon), Philips India Limited (Gurgaon), Toshiba Medical Systems India Pvt. Ltd. (Gurgaon), Hitachi Healthcare Manufacturing, Ltd. (Ahmedabad), Mindray Medical India Pvt. Ltd. (Mumbai), and others.

ID: IN10INHS054 CATEGORY: Healthcare Services GEOGRAPHY: India AUTHOR: Chandani Patel

Buy Now

India Diagnostic Imaging Services Market Executive Summary

The India Diagnostic Imaging Services market size was valued at $9.54 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.9 % from 2022 to 2030 and will reach $17.54 Bn in 2030. The use of several imaging technologies for the diagnosis and treatment of medical diseases is referred to as "diagnostic imaging" in India. These technologies include X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI), ultrasound, and nuclear medicine studies. In India, diagnostic imaging services are widely obtained via hospitals, clinics, and private imaging centres. The nation's universal healthcare system regularly sponsors and provides these treatments, however there are private options available for people who would rather pay out of pocket.

New technology and improvements are continuously being introduced, and this sector of diagnostic imaging is no exception. Companies who can remain ahead of the curve and use the most recent imaging technology would benefit from this. In developing nations like India, China, and Brazil, there is a rising need for diagnostic imaging services. Businesses who can develop a large presence in these markets can take advantage of a sizable growth potential. The need for diagnostic imaging services is increasing as the world's population ages. Cancer, heart disease, and neurological illnesses are just a few of the ailments that older persons are more likely to need medical imaging for.

Diagnostic imaging is anticipated to be used more often as customised medicine spreads. Imaging tests can assist doctors in customising treatment strategies to meet the unique needs of individual patients, producing more successful results. Rapid growth in telemedicine creates potential for businesses that can deliver diagnostic imaging services remotely. This is crucial in locations that lack access to healthcare services, such as rural or underdeveloped areas. Overall, the diagnostic imaging market offers a wide range of possibilities for businesses that can innovate, grow into developing markets, and satisfy shifting patient and healthcare provider expectations.

India diagnostic imaging market

Market Dynamics

Market Growth Drivers

In India, the market for diagnostic imaging is anticipated to develop significantly over the next few years as a result of a number of reasons, including rising healthcare costs, an ageing population, and an increase in the frequency of chronic illnesses. The need for cutting-edge diagnostic tools like MRI, CT, and PET is rising, and this demand is a major growth driver. The Indian government has also put in place a number of programmes to increase access to healthcare, such as the Ayushman Bharat programme, which offers health insurance coverage to more than 500 million people.

Market Restraints

The diagnostic imaging market in India may also be constrained by a number of issues, including expensive equipment prices, a shortage of specialists with the necessary training, and insufficient infrastructure in some areas. Many patients, especially those in rural areas, may not have access to these technologies due to the high cost of diagnostic imaging equipment and the absence of reimbursement policies in many regions of the nation.

Competitive Landscape

Key Players

Wipro GE Healthcare Pvt. Ltd. (Bangalore)
Siemens Healthcare Private Limited (Gurgaon)
Philips India Limited (Gurgaon)
Toshiba Medical Systems India Pvt. Ltd. (Gurgaon)
Hitachi Healthcare Manufacturing, Ltd. (Ahmedabad)
Mindray Medical India Pvt. Ltd. (Mumbai)
Fujifilm India Pvt. Ltd. (Mumbai)
Hologic India Pvt. Ltd. (Gurgaon)
Agfa Healthcare India Pvt. Ltd. (Mumbai)
Canon Medical Systems India Pvt. Ltd. (Gurgaon)

Recent Developments

December 2021: Zionexa is a French firm that creates and sells molecular imaging agents for positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging. Siemens Healthineers recently announced that it has acquired Zionexa.

August 2021: Visionarity, a German company in medical imaging, and Siemens Healthineers have partnered to create AI-based imaging software that will increase the effectiveness and precision of CT and MRI scans.

May 2021: In order to assist individualised cancer diagnosis and treatment, Philips and the University Medical Center Hamburg-Eppendorf (UKE) have established a partnership to create a digital pathology platform that combines data from diverse sources, such as imaging, genetics, and clinical data.

April 2021: Siemens Healthineers will introduce the Somatom X.ceed, a high-resolution computed tomography (CT) scanner that makes it possible to diagnose cancer, cardiovascular disease, and other disorders more quickly and accurately.

February 2021: The US-based Wright Medical Group, a firm specialising in orthopaedic goods and technologies, including imaging and navigation systems for joint replacement procedures, has been acquired by German medical technology giant Stryker.

Healthcare Policies and Regulatory Landscape

The Atomic Energy Regulatory Board (AERB) and the Medical Council of India are in charge of regulating diagnostic imaging procedures and equipment in India (MCI). The following are some of the main rules:

Radiation Safety: Limits on patient exposure to ionising radiation are determined by radiation safety rules, which diagnostic imaging equipment must abide with. Moreover, these standards mandate the routine repair and inspection of imaging equipment.

Medical devices: Diagnostic imaging equipment falls under the definition of a medical device and is subject to the 2017 Medical Device Regulations (MDR). This involves conformity testing, adherence to safety regulations, and registration with the Central Drugs Standard Control Organization (CDSCO).

Data protection: The Personal Data Protection Bill, 2019 (now ongoing legislation), as well as other pertinent data protection laws, must be followed in order to preserve patient data obtained during diagnostic imaging treatments.

Certification: To utilise the equipment and adhere to certain protocols, medical practitioners who operate diagnostic imaging equipment must be qualified.

Patient data collected during diagnostic imaging procedures must be protected in accordance with the Personal Data Protection Bill, 2019 (currently pending legislation) and other relevant data protection regulations.

Approval: AERB approval is required before new diagnostic imaging technology may be employed in clinical settings.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Segmentation

Diagnostic Imaging Services Market Segmentation

By Product

Six product categories make up the market: mammography systems, CT scanners, ultrasound, MRI, and X-ray machines. The technology expected to expand the fastest during the projected period is CT scanners. Their broad application in hospitals and imaging centres for cancer and pulmonary screening, the expansion of their application horizon to include dentistry and interventional procedures, the availability of reimbursements in developed countries, and the ongoing digitalization of healthcare systems all contribute to their significant growth potential.

X-ray Imaging Systems
By Technology
- X-ray Digital Imaging Systems
  - Direct Radiography (DR)
  - Computed Radiography (CR)
- X-ray Analog Imaging Systems
By Portability
Stationary Systems
Portable Systems
Computed Tomography (CT) Scanners
Conventional CT systems
Cone Beam CT Systems (CBCT)
High-slice CT Scanners
Mid-slice CT Scanners
Low-slice CT Scanners
By Technology
2D Ultrasound
3D and 4D Ultrasound
Doppler Ultrasound
Trolley/Cart-based Ultrasound Systems
Compact/Portable Ultrasound Systems
Conventional CT Systems Market, by Technology
Closed MRI
Open MRI
High- and Very-high-field MRI Systems
Low-to-mid-field MRI Systems
Ultra-high-field MRI Systems
Ultrasound Systems
Standalone SPECT Systems
Hybrid SPECT Systems
By Technology
By Portability
Magnetic Resonance Imaging (MRI) Systems
By Architecture
By Field Strength
Nuclear Imaging Systems
SPECT Systems
Hybrid PET Systems
Mammography Systems

By Application

The market is divided into several modalities, such as mammography systems, MRI systems, ultrasound systems, X-ray imaging systems, CT scanners, and nuclear imaging systems, based on the applications they are used for. Cardiology under CT scanners, brain and neurological MRI under MRI systems, radiology and general imaging under ultrasound systems, general radiography applications under X-ray imaging systems, and cancer under nuclear imaging systems made up the majority of the applications in 2021. Among all application categories of the diagnostic imaging market in 2021, general radiography applications under the X-ray imaging systems application represented the greatest market share.

X-ray Imaging Systems
- General Radiography
- Dental
- Fluoroscopy
MRI Systems
Brain & Neurological MRI
Spine & Musculoskeletal MRI
Vascular MRI
Pelvic & Abdominal MRI
Breast MRI
Cardiac MRI
Radiology/General Imaging
Cardiology
Obstetrics/Gynecology
Urology
Vascular
Other Applications
Cardiology
Oncology
Neurology
Other Applications
Cardiology
Oncology
Neurology
Other Applications
Ultrasound Systems
CT Scanners
Nuclear Imaging Systems
Mammography Systems

By End User

The various end-user segments of the worldwide diagnostic imaging services market include hospitals, ambulatory surgical centres, diagnostic centres, and others. Hospitals are the main consumers of diagnostic imaging services, making them a critical market for service providers. Hospitals see a large influx of patients because they offer a wide variety of diagnostic imaging technology for patients. Due to the rise in the recommendation of diagnostic imaging tests for speedy and precise detection of patient medical conditions, the hospitals sector held the highest share of the market in 2022.

Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.